BioLargo, Inc. (BLGO)
0.0809
0.00 (0.00%)
USD |
OTCM |
Oct 02, 16:00
BioLargo EPS Diluted (Quarterly) : -0.0086 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.0086 |
| March 31, 2026 | -0.0072 |
| December 31, 2025 | -0.0094 |
| September 30, 2025 | -0.021 |
| June 30, 2025 | -0.0039 |
| March 31, 2025 | -0.0038 |
| December 31, 2024 | -0.0034 |
| September 30, 2024 | -0.0018 |
| June 30, 2024 | -0.0015 |
| March 31, 2024 | -0.0014 |
| December 31, 2023 | -0.0025 |
| September 30, 2023 | -0.0042 |
| June 30, 2023 | -0.0047 |
| March 31, 2023 | -0.0009 |
| December 31, 2022 | -0.0039 |
| September 30, 2022 | -0.0019 |
| June 30, 2022 | -0.0046 |
| March 31, 2022 | -0.0063 |
| December 31, 2021 | -0.0099 |
| September 30, 2021 | -0.0051 |
| June 30, 2021 | -0.0066 |
| March 31, 2021 | -0.007 |
| December 31, 2020 | -0.0098 |
| September 30, 2020 | -0.01 |
| June 30, 2020 | -0.0134 |
| Date | Value |
|---|---|
| March 31, 2020 | -0.0135 |
| December 31, 2019 | -0.016 |
| September 30, 2019 | -0.0235 |
| June 30, 2019 | -0.0123 |
| March 31, 2019 | -0.0181 |
| December 31, 2018 | -0.0153 |
| September 30, 2018 | -0.0173 |
| June 30, 2018 | -0.03 |
| March 31, 2018 | -0.02 |
| December 31, 2017 | -0.0221 |
| September 30, 2017 | -0.0214 |
| June 30, 2017 | -0.0246 |
| March 31, 2017 | -0.02 |
| December 31, 2016 | -0.02 |
| September 30, 2016 | -0.03 |
| June 30, 2016 | -0.02 |
| March 31, 2016 | -0.02 |
| December 31, 2015 | -0.0146 |
| September 30, 2015 | -0.02 |
| June 30, 2015 | -0.02 |
| March 31, 2015 | -0.01 |
| December 31, 2014 | -0.009 |
| September 30, 2014 | -0.01 |
| June 30, 2014 | -0.01 |
| March 31, 2014 | -0.01 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Olin Corp. | -0.1168 |
| Stepan Co. | 0.9994 |
| Ascent Industries Co. | 0.0735 |
| Solesence, Inc. | -0.0022 |
| The Chemours Co. | -1.812 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -4.00M |
| Revenue (Quarterly) | 1.248M |
| Total Expenses (Quarterly) | 4.015M |
| Enterprise Value | 29.63M |
| Gross Profit Margin (Quarterly) | 51.52% |
| Profit Margin (Quarterly) | -320.5% |
| Earnings Yield | -57.13% |
| Normalized Earnings Yield | -57.00 |